TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 305 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $248 | +69.9% | 16,043 | +73.1% | 0.00% | +200.0% |
Q2 2023 | $146 | -4.6% | 9,268 | 0.0% | 0.00% | -50.0% |
Q1 2023 | $153 | -99.9% | 9,268 | -4.7% | 0.00% | +100.0% |
Q1 2022 | $139,000 | -58.3% | 9,729 | -60.2% | 0.00% | -50.0% |
Q4 2021 | $333,000 | -16.8% | 24,430 | 0.0% | 0.00% | 0.0% |
Q3 2021 | $400,000 | -2.9% | 24,430 | -0.2% | 0.00% | 0.0% |
Q2 2021 | $412,000 | -32.5% | 24,469 | -26.7% | 0.00% | -33.3% |
Q1 2021 | $610,000 | +37.1% | 33,383 | +36.4% | 0.00% | +50.0% |
Q4 2020 | $445,000 | +1.8% | 24,468 | 0.0% | 0.00% | -33.3% |
Q3 2020 | $437,000 | -0.5% | 24,468 | -0.0% | 0.00% | -25.0% |
Q2 2020 | $439,000 | +19.3% | 24,472 | +0.8% | 0.00% | +33.3% |
Q1 2020 | $368,000 | -23.2% | 24,272 | -0.1% | 0.00% | -25.0% |
Q4 2019 | $479,000 | +14.6% | 24,297 | +0.0% | 0.00% | +33.3% |
Q3 2019 | $418,000 | -2.1% | 24,293 | +0.6% | 0.00% | 0.0% |
Q2 2019 | $427,000 | -6.4% | 24,147 | +8.0% | 0.00% | -25.0% |
Q1 2019 | $456,000 | – | 22,362 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TFG Asset Management GP Ltd | 1,903,662 | $29,449,652 | 5.37% |
MANAGED ASSET PORTFOLIOS, LLC | 1,736,416 | $26,862,356 | 4.12% |
Y.D. More Investments Ltd | 1,381,550 | $21,372,579 | 4.11% |
Clean Yield Group | 533,157 | $8,167,965 | 3.62% |
XY Capital Ltd | 143,697 | $2,222,993 | 1.28% |
Mondrian Investment Partners LTD | 4,081,715 | $61,225,725 | 1.26% |
Capricorn Fund Managers Ltd | 204,892 | $3,169,679 | 1.10% |
Legacy Wealth Asset Management, LLC | 124,967 | $1,933,239 | 0.71% |
HAP Trading, LLC | 263,679 | $4,079,114 | 0.65% |
BRANDES INVESTMENT PARTNERS, LP | 1,802,036 | $27,877,493 | 0.54% |